Skip to main content
future60.co.uk
Main menu
Home
The Association of German Chambers of Commerce and Industry
The Commonwealth Enterprise and Investment Council
United States Trade Representative
You are here
Home
Navigation
Feed aggregator
Sources
User login
Username
*
Password
*
Request new password
Feed aggregator
Quarterly epidemiological commentary: mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to July to September 2022)
JCVI
-
Thu, 04/11/2024 - 09:30
Quarterly epidemiological commentary: Mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to July to September 2023)
JCVI
-
Thu, 04/11/2024 - 09:30
Quarterly epidemiological commentary: mandatory MRSA, MSSA and Gram-negative bacteraemia, and C. difficile infection data (up to January to March 2022)
JCVI
-
Thu, 04/11/2024 - 09:30
Quarterly epidemiological commentary: Mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to October to December 2023)
JCVI
-
Thu, 04/11/2024 - 09:30
Subject knowledge enhancement (SKE) course directory
JCVI
-
Thu, 04/11/2024 - 09:30
MRSA, MSSA, Gram-negative bacteraemia and CDI: quarterly report
JCVI
-
Thu, 04/11/2024 - 09:30
Trends in meticillin resistant (MRSA) and meticillin susceptible (MSSA) Staphylococcus aureus, Gram-negative bacteraemia and Clostridioides difficile infection.
Quarterly epidemiological commentary: mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to April to June 2022)
JCVI
-
Thu, 04/11/2024 - 09:30
Quarterly epidemiological commentary: Mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to October to December 2022)
JCVI
-
Thu, 04/11/2024 - 09:30
Quarterly epidemiological commentary: mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections data (up to October to December 2021)
JCVI
-
Thu, 04/11/2024 - 09:30
Quarterly epidemiological commentary: Mandatory Gram-negative bacteraemia, MRSA, MSSA and C. difficile infections (data up to April to June 2023)
JCVI
-
Thu, 04/11/2024 - 09:30
Clostridioides difficile ribotyping network (CDRN): guide to services
JCVI
-
Thu, 04/11/2024 - 09:30
The CDRN laboratory provides timely access to Clostridioides difficile culture, ribotyping and DNA fingerprinting services, according to standardised submission criteria.
Mr A Naisbitt v Fortnight Ltd (in Administration) and Freedom Technology Ltd: 3313550/2023
JCVI
-
Thu, 04/11/2024 - 09:01
Employment Tribunal decision.
Mrs J Leino v P O'Halloran/GCA Chartered Accountants: 2302807/2023
JCVI
-
Thu, 04/11/2024 - 08:55
Employment Tribunal decision.
Mr F Edreira v Severn Waste Services Ltd: 1307859/2022
JCVI
-
Thu, 04/11/2024 - 08:46
Employment Tribunal decision.
A guide to the spring 2024 COVID-19 vaccination campaign
JCVI
-
Thu, 04/11/2024 - 08:38
Mr D Hughes v Costain Ltd and ME Global Resources Ltd: 1304006/2023 and 1304002/2023
JCVI
-
Thu, 04/11/2024 - 08:36
Employment Tribunal decision.
Dr A Chisholm v Dr S Gill and Dr A Thomas (a Partnership) T/a Griffiths Practice: 1303736/2023
JCVI
-
Thu, 04/11/2024 - 08:11
Employment Tribunal decision.
Decision on Zoho IT Service Ltd
JCVI
-
Wed, 04/10/2024 - 16:03
Company Names Tribunal decision: Thyssenkrupp Avionic Ltd
JCVI
-
Wed, 04/10/2024 - 16:03
Decision for applicant Thysenkrupp AG registration number 15104584, applicant successful.
COVID-19 vaccine product information
JCVI
-
Wed, 04/10/2024 - 15:16
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »